التفاصيل البيبلوغرافية
| العنوان: |
The observational clinical registry (cohort design) of the European Reference Network on Rare Adult Solid Cancers: The protocol for the rare head and neck cancers |
| المؤلفون: |
Trama, Annalisa, Licitra, Lisa, Cavalieri, Stefano, Bonfarnuzzo, Simone, Baili, Paolo, Ciarfella, Antonio, Parente, Pablo, Almadori, Giovanni, Ansarin, Mohssen, Bacigalupo, Almalina, Baumeister, Philipp, Baujat, Bertrand, Bossi, Paolo, Cavalera, Elisa, Cercato, Maria Cecilia, Dieleman, Francois, Fakhry, Nicolas, Ferraresi, Virginia, Gaino, Francesca, Galizia, Danilo, Halamkova, Jana, Halme, Elina, Hardillo, Jose, Hofauer, Benedikt, Kinloch, Emma, Livi, Lorenzo, Locati, Laura Deborah, Mattheis, Stefan, Mercante, Giuseppe, Mirabile, Aurora, Molteni, Gabriele, Orlandi, Ester, Persio, Roberto, Sciallero, Stefania, Smeele, Ludi, Tagliabue, Marta, Valentini, Valentino, Van Harpen, Carla, Westphalen, Christoph Benedikt, Botta, Laura |
| المساهمون: |
Raza, Afsheen, Associazione Italiana Oncologia Cervico, Italian Ministry of Heath, European Union’s Health Programme |
| المصدر: |
PLOS ONE ; volume 18, issue 3, page e0283071 ; ISSN 1932-6203 |
| بيانات النشر: |
Public Library of Science (PLoS) |
| سنة النشر: |
2023 |
| المجموعة: |
PLOS Publications (via CrossRef) |
| الوصف: |
Introduction Care for head and neck cancers is complex in particular for the rare ones. Knowledge is limited and histological heterogeneity adds complexity to the rarity. There is a wide consensus that to support clinical research on rare cancer, clinical registries should be developed within networks specializing in rare cancers. In the EU, a unique opportunity is provided by the European Reference Networks (ERN). The ERN EURACAN is dedicated to rare adults solid cancers, here we present the protocol of the EURACAN registry on rare head and neck cancers (ClinicalTrials.gov Identifier: NCT05483374). Study design Registry-based cohort study including only people with rare head and neck cancers. Objectives to help describe the natural history of rare head and neck cancers; to evaluate factors that influence prognosis; to assess treatment effectiveness; to measure indicators of quality of care. Methods Settings and participants It is an hospital based registry established in hospitals with expertise in head and neck cancers. Only adult patients with epithelial tumours of nasopharynx; nasal cavity and paranasal sinuses; salivary gland cancer in large and small salivary glands; and middle ear will be included in the registry. This registry won’t select a sample of patients. Each patient in the facility who meets the above mentioned inclusion criteria will be followed prospectively and longitudinally with follow-up at cancer progression and / or cancer relapse or patient death. It is a secondary use of data which will be collected from the clinical records. The data collected for the registry will not entail further examinations or admissions to the facility and/or additional appointments to those normally provided for the patient follow-up. Variables Data will be collected on patient characteristics (eg. patient demographics, lifestyle, medical history, health status); exposure data (eg. disease, procedures, treatments of interest) and outcomes (e.g. survival, progression, progression-free survival, etc.). In ... |
| نوع الوثيقة: |
article in journal/newspaper |
| اللغة: |
English |
| DOI: |
10.1371/journal.pone.0283071 |
| الإتاحة: |
https://doi.org/10.1371/journal.pone.0283071Test |
| حقوق: |
http://creativecommons.org/licenses/by/4.0Test/ |
| رقم الانضمام: |
edsbas.1553F451 |
| قاعدة البيانات: |
BASE |
